1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for 'CFS'.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 5th May 2025 is here.
    Dismiss Notice
  3. Welcome! Read the Core Purpose and Values of our forum.
    Dismiss Notice

Long Covid research

Post and discuss Long Covid research papers (excluding psychosomatic research) here

Page 30 of 130
Sort By:
Title Start Date
Replies Views
Last Message ↓
  1. SNT Gatchaman

    Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes, 2024, Zhang et al.

    SNT Gatchaman, Feb 2, 2024
    Replies:
    12
    Views:
    1,625
    SNT Gatchaman
    Oct 16, 2024
  2. Mij

    CCL2-mediated endothelial injury drives cardiac dysfunction in long COVID, 2024, Dilip Thomas et al

    Mij, Oct 14, 2024
    Replies:
    4
    Views:
    912
    Mij
    Oct 15, 2024
  3. SNT Gatchaman

    Macro- and Microstructural White Matter Differences in Neurologic Postacute Sequelae of SARS-CoV-2 Infection, 2024, O’Connor et al.

    SNT Gatchaman, Oct 11, 2024
    Replies:
    3
    Views:
    1,149
    SNT Gatchaman
    Oct 14, 2024
  4. SNT Gatchaman

    Exploring common pathogenic association between [EBV] and [LC] by integrating RNA-Seq and molecular dynamics simulations, 2024, Kanwal+Zhang

    SNT Gatchaman, Oct 13, 2024
    Replies:
    1
    Views:
    763
    Hutan
    Oct 13, 2024
  5. Dolphin

    Trial Report Exploring the role of galectin-9 and artemin as biomarkers in long COVID with [CFS]: links to inflammation and cognitive function, 2024, Elahi et al

    Dolphin, Sep 5, 2024 ... 2
    Replies:
    20
    Views:
    2,022
    Lindberg
    Oct 12, 2024
  6. Dolphin

    Post-viral symptoms and conditions are more frequent in COVID-19 than influenza, but not more persistent, 2024, Tesch

    Dolphin, Feb 11, 2024
    Replies:
    3
    Views:
    1,233
    Peter Trewhitt
    Oct 12, 2024
  7. Andy

    Review A review of intravenous immunoglobulin in the treatment of neuroimmune conditions, acute COVID-19 infection, and [LC]... 2024 Melamed et al

    Andy, Oct 11, 2024
    Replies:
    0
    Views:
    1,110
    Andy
    Oct 11, 2024
  8. Jonathan Edwards

    Is joint hypermobility linked to self-reported non-recovery from COVID-19? Case–control evidence ... , 2024, Eccles et al

    Jonathan Edwards, Mar 20, 2024 ... 2
    Replies:
    34
    Views:
    4,356
    Jonathan Edwards
    Oct 11, 2024
  9. Mij

    COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type, 2024, James R. Hilser et al

    Mij, Oct 9, 2024
    Replies:
    0
    Views:
    1,021
    Mij
    Oct 9, 2024
  10. Sparkly Unicorn

    Post COVID-19 syndrome among 5248 healthcare workers in England: longitudinal findings from NHS CHECK, 2024, Dempsey et al

    Sparkly Unicorn, Oct 3, 2024
    Replies:
    15
    Views:
    1,564
    rvallee
    Oct 9, 2024
  11. Dolphin

    Trial Report Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study, 2024, Swank

    Dolphin, Oct 9, 2024
    Replies:
    1
    Views:
    1,141
    Dolphin
    Oct 9, 2024
  12. Mij

    Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations, 2024, Catarina Rua et al

    Mij, Oct 8, 2024
    Replies:
    1
    Views:
    377
    SNT Gatchaman
    Oct 8, 2024
  13. SNT Gatchaman

    Quantitative susceptibility mapping at 7 Tesla in COVID-19: mechanistic and outcome associations, 2023, Rua et al.

    SNT Gatchaman, Nov 24, 2023
    Replies:
    6
    Views:
    1,945
    Nightsong
    Oct 8, 2024
  14. Kalliope

    Post-COVID-19 Condition Fatigue Outcomes Among Danish Residents, O´Regan et al, 2024

    Kalliope, Oct 7, 2024
    Replies:
    1
    Views:
    1,023
    Kalliope
    Oct 7, 2024
  15. Andy

    Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19, 2022, Charnley et al

    Andy, Jun 13, 2022
    Replies:
    3
    Views:
    854
    SNT Gatchaman
    Oct 7, 2024
  16. SNT Gatchaman

    Cell invasive amyloid assemblies from SARS-CoV-2 peptides can form multiple polymorphs with varying neurotoxicity, 2024, Sanislav, Annesley et al.

    SNT Gatchaman, Oct 4, 2024
    Replies:
    2
    Views:
    970
    SNT Gatchaman
    Oct 7, 2024
  17. SNT Gatchaman

    No reduced serum serotonin levels in patients with post-acute sequelae of COVID-19, 2024, Mathé et al.

    SNT Gatchaman, Oct 3, 2024
    Replies:
    5
    Views:
    1,053
    ME/CFS Skeptic
    Oct 6, 2024
  18. Mij

    Post-COVID-19 condition—Clinical phenotyping in practice, 2024, Karen Humkamp et al

    Mij, Oct 4, 2024
    Replies:
    2
    Views:
    435
    rvallee
    Oct 5, 2024
  19. forestglip

    Gastrointestinal manifestations of long COVID, 2024, King

    forestglip, Oct 5, 2024
    Replies:
    2
    Views:
    457
    rvallee
    Oct 5, 2024
  20. EndME

    Serotonin reduction in post-acute sequelae of viral infection, 2023, Wong, Cherry et al

    EndME, Oct 16, 2023 ... 2
    Replies:
    26
    Views:
    5,562
    SNT Gatchaman
    Oct 5, 2024
Showing threads 581 to 600 of 2,596

Thread Display Options

Loading...
Page 30 of 130